In our study, we assessed the prognostic value of the increment of postoperative CEA and CA19-9 in non-metastatic GC and confirmed its superiority of prognosis compare to the level of preoperative CEA and CA19-9. This evidence concerns the gene CEACAM5 and gastric cancer.